The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene
Abstract
Mucoepidermoid carcinomas (MECs) of the salivary and bronchial glands are characterized by a recurrent t(11;19)(q21;p13) translocation resulting in a MECT1–MAML2 fusion in which the CREB‐binding domain of the CREB coactivator MECT1 (also known as CRTC1, TORC1 or WAMTP1) is fused to the transactivation domain of the Notch coactivator MAML2. To gain further insights into the molecular pathogenesis of MECs, we cytogenetically and molecularly characterized a series of 29 MECs. A t(11;19) and/or an MECT1–MAML2 fusion was detected in more than 55% of the tumors. Several cases with cryptic rearrangements that resulted in gene fusions were detected. In fusion‐negative MECs, the most common aberration was a single or multiple trisomies. Western blot and immunohistochemical studies demonstrated that the MECT1–MAML2 fusion protein was expressed in all MEC‐specific cell types. In addition, cotransfection experiments showed that the fusion protein colocalized with CREB in homogeneously distributed nuclear granules. Analyses of potential downstream targets of the fusion revealed differential expression of the cAMP/CREB (FLT1 and NR4A2) and Notch (HES1 and HES5) target genes in fusion‐positive and fusion‐negative MECs. Moreover, clinical follow‐up studies revealed that fusion‐positive patients had a significantly lower risk of local recurrence, metastases, or tumor‐related death compared to fusion‐negative patients (P = 0.0012). When considering tumor‐related deaths only, the estimated median survival for fusion‐positive patients was greater than 10 years compared to 1.6 years for fusion‐negative patients. These findings suggest that molecularly classifying MECs on the basis of an MECT1–MAML2 fusion is histopathologically and clinically relevant and that the fusion is a useful marker in predicting the biological behavior of MECs. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International System for Human Cytogenetic Nomenclature
National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,840
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Measurement of co‐localization of objects in dual‐colour confocal images
MANDERS, E. M. M., VERBEEK, F. J., & ATEN, J. A. (1993) · Journal of Microscopy · doi:10.1111/j.1365-2818.1993.tb03313.x · Cited by 2,154
Conkright, M. D., Canettieri, G., Screaton, R., Guzman, E., Miraglia, L., Hogenesch, J. B., & Montminy, M. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.013 · Cited by 602
Tonon, G., Modi, S., Wu, L., Kubo, A., Coxon, A. B., Komiya, T., O'Neil, K., Stover, K., El-Naggar, A., Griffin, J. D., et al. (2003) · Nature Genetics · doi:10.1038/ng1083 · Cited by 567
Iourgenko, V., Zhang, W., Mickanin, C., Daly, I., Jiang, C., Hexham, J. M., Orth, A. P., Miraglia, L., Meltzer, J., Garza, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932773100 · Cited by 367
Wu, L., Sun, T., Kobayashi, K., Gao, P., & Griffin, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7688-7700.2002 · Cited by 267
Bittinger, M. A., McWhinnie, E., Meltzer, J., Iourgenko, V., Latario, B., Liu, X., Chen, C. H., Song, C., Garza, D., & Labow, M. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.002 · Cited by 229
Enlund, F., Behboudi, A., Andrén, Y., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.007 · Cited by 155
Self-citationTransforming activity of MECT1‐MAML2 fusion oncoprotein is mediated by constitutive CREB activation
Wu, L., Liu, J., Gao, P., Nakamura, M., Cao, Y., Shen, H., & Griffin, J. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600719 · Cited by 144
Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
Coxon, A., Rozenblum, E., Park, Y., Joshi, N., Tsurutani, J., Dennis, P., Kirsch, I., & Kaye, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1125 · Cited by 144
Sjögren, H., Meis‐Kindblom, J. M., Örndal, C., Bergh, P., Ptaszyński, K., Åman, P., Kindblom, L., & Stenman, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63875-8 · Cited by 114
Self-citationLin, S., Oyama, T., Nagase, T., Harigaya, K., & Kitagawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209529200 · Cited by 103
Skálová, A., Lehtonen, H., von Boguslawsky, K., & Leivo, I. V. V. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90014-0 · Cited by 103
Self-citationHahn, Y., Bera, T. K., Gehlhaus, K., Kirsch, I. R., Pastan, I. H., & Lee, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405490101 · Cited by 92
Cited by
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Pao, W., & Chmielecki, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2947 · Cited by 1,083
“As MECs harbour a recurrent mucoepidermoid carcinoma translocated 1 ( MECT1 )–mastermind-like 2( MAML2 )fusio”
BackgroundPersson, M., Andrén, Y., Mark, J., Horlings, H. M., Persson, F., & Stenman, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909114106 · Cited by 788
Self-citation
Metadata
- Authors
- Behboudi, A., Enlund, F., Winnes, M., Andrén, Y., Nordkvist, A., Leivo, I., Flaberg, E., Szekely, L., Mäkitie, A., Grenman, R., Mark, J., & Stenman, G.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2006-01-27
- Volume
- 45
- Issue
- 5
- Pages
- 470-481
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2129307197
- Cited by
- 322
- References
- 15
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.